Different <i>TBX5</i> interactions in heart and limb defined by Holt–Oram syndrome mutations
Craig T. Basson(Howard Hughes Medical Institute), Christine E. Seidman(Harvard University), Mary Ella Pierpont(University of Minnesota Medical Center), Jonathan G. Seidman(Harvard University), Sonia F. Mesquita(Howard Hughes Medical Institute), Stanislawa Weremowicz(Brigham and Women's Hospital), Alexandre C. Pereira(University of Washington), Taosheng Huang(The Centre for Health (New Zealand)), Roberto Quadrelli(Howard Hughes Medical Institute), Christoph W. Müller(European Molecular Biology Laboratory), Margherita Silengo(University of Turin), David R. Bachinsky(Howard Hughes Medical Institute), Cynthia C. Morton(Broad Institute), Mitsuhiro Kamisago(Brigham and Women's Hospital), Alicia Vaglio(Howard Hughes Medical Institute), José Eduardo Krieger(Howard Hughes Medical Institute), Giovanni Romeo(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Margherita Lerone(Howard Hughes Medical Institute), Robert C. Lin(Howard Hughes Medical Institute), Rina Bruzzone(Howard Hughes Medical Institute)
Cited by 365
Related Papers
Contemporary Definitions and Classification of the Cardiomyopathies
|Circulation|2006|3.4k
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
|Circulation|2011|2.1k
Cells of the adult human heart
|Nature|2020|1.8k
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy
|Journal of the American College of Cardiology|2003|1.6k